Phase III medical Company Spectral Medical Inc. (TSX: EDT, OTC: EDTXF, Forum) is offering investors a personal look into its advanced operations to treat patients suffering from septic shock. The Company's next corproate presenttion takes place Thursday, July 10th Metropolitan Grill - 820 Second Avenue, Seattle, Washington.
For more on this event, click here.
Its unique product to treat septic shock, Toraymyxin (PMX), has been approved for therapeutic use in Japan and Europe, and has been used safely and effectively on more than 150,000 patients to date. Spectral is holding another presentation in Vancouver today at 1pm.
FULL DISCLOSURE: Spectral Medical Inc. is a client of Stockhouse Publishing.